Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover why allocating more bonds as you age can stabilize withdrawals and protect capital. A brief primer on safer retirement strategies.
27,889 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Delaware introduces a dedicated licensing regime for stablecoin issuers, placing them under the State Bank Commission...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
Local towns are pushing back on megascale data centers even as tech giants accelerate capex toward a multi-trillion-d...
As AI rivals surge and cloud demand shifts, investors question Microsoft’s staying power in the Magnificent 7. The de...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
A DRAM-focused memory ETF delivered triple-digit gains in 2026, outperforming many AI names as investors weighed AI i...
The ProShares Ultra Technology ETF fell sharply on Friday as NVIDIA and Broadcom headlines collided with tech stocks,...
Bezos-backed Prometheus closed a $12 billion private round, signaling a major push into AI-enabled industrial design ...
Strive's CEO says recent STRC and SATA declines were driven by leverage-induced liquidations rather than weakening fu...